| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/24/2003 | US20030138897 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138896 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138894 Angiotensin converting enzyme-2/like polypeptides and inhibitors for treating and/or prevention of hypertension, congestive heart failure, stroke and atherosclerotic heart disease |
| 07/24/2003 | US20030138893 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138892 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138891 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138890 Anticarcinogenic/antitumor/antiarthritic/antiinflammatory agents; analgesics; angiogenesis inhibitors; gene expression inhibition |
| 07/24/2003 | US20030138889 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138888 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138887 For release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |
| 07/24/2003 | US20030138886 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138885 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138884 APRIL- a novel protein with growth effects |
| 07/24/2003 | US20030138883 For release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |
| 07/24/2003 | US20030138882 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138881 Novel co-stimulatory molecules |
| 07/24/2003 | US20030138878 Culturing genetically engineered methanotrophic bacteria to produce polypeptide products for use in animal feeds and food processing |
| 07/24/2003 | US20030138866 Novel Osp-C derived peptide fragments |
| 07/24/2003 | US20030138865 Incubating LN3 cells expressing Peripheral-type benzodiazepine receptors (PBR)/(HRPC) with antitumor agents and monitoring tumor progression; antisense therapy; drug screening; antiandrogens |
| 07/24/2003 | US20030138856 Process for the measurement of dinophysistoxin and yessotoxin |
| 07/24/2003 | US20030138854 Method for determining BAGE expression |
| 07/24/2003 | US20030138848 3D structure of polypeptides containing a TPR-structure motif with chaperone-binding function, crystals thereof and compounds for inhibition of said polypeptides |
| 07/24/2003 | US20030138844 Antibodies binding a gamma carboxyglutamic acid displaying epitope |
| 07/24/2003 | US20030138843 Generating/measuring improved polypeptide solubility in vitro/in situ using reporter molecule and mutagenesis |
| 07/24/2003 | US20030138839 Polypeptide comprising ubiquitination regulating domain; antiproliferative agents; neuroprotectants; cancer diagnosis |
| 07/24/2003 | US20030138836 Detecting modulators of a silencing mediator for retinoic acid receptor; relieving suppression of steroid/thyroid hormone receptor activity; GAL4 DNA binding domains |
| 07/24/2003 | US20030138835 Tumor suppressors |
| 07/24/2003 | US20030138826 Compositions, methods, and kits relating to resistin-like molecules |
| 07/24/2003 | US20030138822 Polynucleotides and polypeptides, materials incorporating them and methods for using them |
| 07/24/2003 | US20030138820 Sugar transport protein for use in diagnosis and treatment of diabetes, hypertriglyceridemia and hyperinsulinemia |
| 07/24/2003 | US20030138818 G-protein coupled receptors |
| 07/24/2003 | US20030138817 G protein coupled receptor protein, production, and use thereof |
| 07/24/2003 | US20030138810 High throughput method for discovery of gene clusters |
| 07/24/2003 | US20030138808 Polypeptides wherein epitopes correspond to proteosome cleavage product of tyrosinase and major histocompatability complex; vaccine |
| 07/24/2003 | US20030138803 Identification and use of molecules implicated in pain |
| 07/24/2003 | US20030138802 Glycosyltransferases (SMAP-1); transmembrane traps (TMT); fetal hepatocytes for regulation of apoptosis and inflammatory reactions; alzheimer's treatment |
| 07/24/2003 | US20030138799 Monitoring morphological adjustment in cell structure of tissue transfected with cancer gene; gut-enriched kruppel-like factor/epithelial zinc finger (GKLF); side effect reduction; antitumor/antiproliferative agents |
| 07/24/2003 | US20030138795 Polynucleotide encoding a novel human growth factor with homology to epidermal growth factor, BGS-8, expressed highly in immune tissue |
| 07/24/2003 | US20030138776 Polymorphic human GABAA receptor alpha-6 subunit |
| 07/24/2003 | US20030138772 Polymerase chain reactions to screen and isolate parvovirus DNA obtained from tissue and/or cells without coinfection by helper viruses; gene therapy |
| 07/24/2003 | US20030138771 Detecting target (open reading frames) of bactericides/microbiocides; immunoaffinity chromatography/immunoprecipitation assay |
| 07/24/2003 | US20030138769 Immunogenic HBc chimer particles having enhanced stability |
| 07/24/2003 | US20030138461 Process for the in vitro culture of different stages of tissular parasites |
| 07/24/2003 | US20030138459 Method of vaccination through serotype rotation |
| 07/24/2003 | US20030138458 HCV E1E2 vaccine compositions |
| 07/24/2003 | US20030138457 Such as F protein of Paramyxovirus SV5 strain; this recombinant Rhabdovirus may express other non-Rhabdovirus attachment proteins and/or an enhancer protein; for diagnostic and therapeutic compositions for treatment of diseases |
| 07/24/2003 | US20030138456 Vaccines expressed in plants |
| 07/24/2003 | US20030138454 Vaccination method |
| 07/24/2003 | US20030138452 Chemokine-tumor antigen fusion proteins as cancer vaccines |
| 07/24/2003 | US20030138451 Contacting a sample from the blood of a human or animal with the chimeric polypeptide and determining the presence of visceral Leishmaniosis by detection of binding between polypeptide and Leishmania infantum antibodies |
| 07/24/2003 | US20030138450 Plasmodium falciparum AMA-1 protein and uses thereof |
| 07/24/2003 | US20030138449 Method of administering FimH protein as a vaccine for urinary tract infections |
| 07/24/2003 | US20030138447 Derivatives of choline binding proteins for vaccines |
| 07/24/2003 | US20030138446 Nucleic acid vaccine to protect salmon against piscirickettsiosis salmonis a gramnegative bacteria |
| 07/24/2003 | US20030138445 gp41 antigen |
| 07/24/2003 | US20030138444 Composition and method for treating HIV infection |
| 07/24/2003 | US20030138443 Cloning of chicken anemia virus DNA |
| 07/24/2003 | US20030138442 Protein- or polynucleic acid-based vaccine which protects a pig against porcine reporductive and respiratory syndrome |
| 07/24/2003 | US20030138441 A polynucleotide sequence which encodes a Dermatophagoides dust mite protein, wherein the codon usage pattern of the polynucleotide sequence resembles that of highly expressed mammalian genes |
| 07/24/2003 | US20030138440 Multimeric proteins and methods of making and using same |
| 07/24/2003 | US20030138439 Polypeptides fused to heterologous polypeptide sequences, antibodies which bind to above polypeptides; |
| 07/24/2003 | US20030138438 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/24/2003 | US20030138426 Human tumor necrosis factor receptor-like proteins TR11, TR11SV1, and TR11SV2 |
| 07/24/2003 | US20030138424 An antibody capable of inhibiting the binding between parathyroid hormone related protein (PTHrP) and a receptor; antagonists; systemic disorders caused by cancer; anorexic agents; anemia, electrolyte imbalance; immunotherapy |
| 07/24/2003 | US20030138422 Antibodies against growth and differentiation factor-8 (GDF-8), also known as myostatin, including fragments; muscle and bone degenerative disorders; muscular dystropy/atrophy; antidiabetic agents; congestive obstructive pulmonary disease |
| 07/24/2003 | US20030138420 Administering a tissue factor, e.g., a monoclonal antibody, a human tissue factor binding site polypeptide analog of <50 amino acid residues, by injection into the tissue of the central nervous system, brain and myocardium; anticoagulants |
| 07/24/2003 | US20030138418 Encoding GAVE18, a heretofore unknown G- protein-coupled receptor, involved in cellular signal transduction; antiinflammatory agents; hypotensive agents; antiarrhymia agents; bronchodilation agents; glandular disorders; |
| 07/24/2003 | US20030138412 Inhibition of tumor growth and metastasis by N5 gene |
| 07/24/2003 | US20030138411 Gene expression in monocytes and macrophages |
| 07/24/2003 | US20030138410 Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells |
| 07/24/2003 | US20030138405 An adenovirus encoding an E1A polypeptide unable to bind the tumor suppressor protein retinoblastomas (Rb) may replicate in or kill a cell having a defective Rb pathway but not the non-mutant cells; gliomas; gene therapy; antitumor agents |
| 07/24/2003 | US20030138404 Interferon antagonists useful for the treatment of interferon related diseases |
| 07/24/2003 | US20030138401 Protein based TNF-alpha variants for the treatment of TNF-alpha related disorders |
| 07/24/2003 | US20030138400 Polypeptides that are truncated forms of human chemokine beta-8 |
| 07/24/2003 | CA2841097A1 Albumin fusion proteins |
| 07/24/2003 | CA2765340A1 Novel calpastatin (cast) alleles |
| 07/24/2003 | CA2484556A1 Albumin fusion proteins |
| 07/24/2003 | CA2477348A1 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling |
| 07/24/2003 | CA2475993A1 Defective entities and uses therefor |
| 07/24/2003 | CA2474151A1 Androgen regulated nucleic acid molecules and encoded proteins |
| 07/24/2003 | CA2474044A1 Compositions and methods for identifying transformed cells |
| 07/24/2003 | CA2473570A1 Antisense compounds directed against human csf-1 |
| 07/24/2003 | CA2473229A1 Selective melanin-concentrating hormone type -1 receptor agonists |
| 07/24/2003 | CA2472759A1 Gb virus b based replicons and replicon enhanced cells |
| 07/24/2003 | CA2472579A1 Hiv vaccine and method of use |
| 07/24/2003 | CA2472468A1 Construction of west nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by west nile virus |
| 07/24/2003 | CA2472452A1 Rabbit nuclear cloning method and uses thereof |
| 07/24/2003 | CA2472423A1 Process for producing kiss-1 peptide |
| 07/24/2003 | CA2472381A1 Glycosyltransferase gnt-v having neovascularization action |
| 07/24/2003 | CA2471891A1 Methods of inducing or enhancing connective tissue repair |
| 07/24/2003 | CA2471817A1 Labeling targeting agents with gallium-68 and gallium-67 |
| 07/24/2003 | CA2471480A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 07/24/2003 | CA2471363A1 Albumin fusion proteins |
| 07/24/2003 | CA2470998A1 Anti-angiogenic proteins and fragments and methods of use thereof |
| 07/24/2003 | CA2470503A1 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 07/24/2003 | CA2470421A1 Use of a novel cell surface protease from group b streptococcus |
| 07/24/2003 | CA2470359A1 Assay for the detection of factors that modulate the expression of ingap |
| 07/24/2003 | CA2465178A1 Adapter-directed display system |
| 07/24/2003 | CA2463008A1 Efficient protein expression system |
| 07/24/2003 | CA2417299A1 Isolation of the laminin .gamma.2 gene in horses and its use in diagnosing junctional epidermolysis bullosa |